Research Article
Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database
Table 4
The association between SOX12 expression and clinicopathologic factors.
| | Clinical features | Type | Total | High | Low | value |
| | Age | >60 | 266 (50.19%) | 139 (52.45%) | 127 (47.92%) | 0.3393 | | ≤60 | 264 (49.81%) | 126 (47.55%) | 138 (52.08%) | |
| | Gender | Female | 186 (35.09%) | 85 (32.08%) | 101 (38.11%) | 0.1722 | | Male | 344 (64.91%) | 180 (67.92%) | 164 (61.89%) | |
| | Stage | Stage I | 265 (50.28%) | 115 (43.73%) | 150 (56.82%) | | | Stage II | 57 (10.82%) | 25 (9.51%) | 32 (12.12%) | | | Stage III | 123 (23.34%) | 69 (26.24%) | 54 (20.45%) | | | Stage IV | 82 (15.56%) | 54 (20.53%) | 28 (10.61%) | |
| | Grade | G1 | 14 (2.68%) | 8 (3.07%) | 6 (2.3%) | | | G2 | 227 (43.49%) | 95 (36.4%) | 132 (50.57%) | | | G3 | 206 (39.46%) | 113 (43.3%) | 93 (35.63%) | | | G4 | 75 (14.37%) | 45 (17.24%) | 30 (11.49%) | |
| | T | T1 | 271 (51.13%) | 119 (44.91%) | 152 (57.36%) | | | T2 | 69 (13.02%) | 32 (12.08%) | 37 (13.96%) | | | T3 | 179 (33.77%) | 107 (40.38%) | 72 (27.17%) | | | T4 | 11 (2.08%) | 7 (2.64%) | 4 (1.51%) | |
| | N | N0 | 239 (93.73%) | 115 (90.55%) | 124 (96.88%) | 0.0682 | | N1 | 16 (6.27%) | 12 (9.45%) | 4 (3.12%) | |
| | M | M0 | 420 (84.34%) | 198 (79.52%) | 222 (89.16%) | | | M1 | 78 (15.66%) | 51 (20.48%) | 27 (10.84%) | |
|
|
|
